The EGAPP initiative: lessons learned

The Evaluation of Genomic Applications in Practice and Prevention Working Group was first convened in 2005 to develop and test evidence-based methods for the evaluation of genomic tests in transition from research to clinical and public health practice. Over the ensuing years, the Working Group has...

Full description

Saved in:
Bibliographic Details
Published in:Genetics in medicine 2014-03, Vol.16 (3), p.217-224
Main Authors: Calonge, Ned, Klein, Roger D, Berg, Alfred O, Berg, Jonathan S, Armstrong, Katrina, Botkin, Jeffrey, Campos-Outcalt, Doug, Djulbegovic, Benjamin, Fisher, Nancy L, Ganiats, Theodore G, Haddow, James E, Hayes, Maxine, Janssens, A Cecile JW, Kaye, Celia, Lyman, Donald O, Offit, Kenneth, Pauker, Stephen G, Phillips, Kathryn A, Piper, Margaret, Richards, Carolyn Sue, Scott, Joan A, Strickland, Ora L, Teutsch, Steven, Tunis, Sean R, Veenstra, David L, Williams, Marc S, Zallen, Doris T
Format: Article
Language:English
Subjects:
Evidence-Based Medicine - methods
Genetic Testing - methods
Genome-Wide Association Study - methods
Genomes
Genomics - methods
Humans
Public Health - methods
Translational Research, Biomedical - methods
Working groups
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Evaluation of Genomic Applications in Practice and Prevention Working Group was first convened in 2005 to develop and test evidence-based methods for the evaluation of genomic tests in transition from research to clinical and public health practice. Over the ensuing years, the Working Group has met 26 times, publishing eight recommendation statements, two methods papers, and one outcomes paper, as well as planning and serving as technical experts on numerous associated systematic reviews. Evaluation of Genomic Applications in Practice and Prevention methods have evolved to address implications of the proliferation of genome-wide association studies and are currently expanding to face challenges expected from clinical implementation of whole-genome sequencing tests. In this article, we review the work of the Evaluation of Genomic Applications in Practice and Prevention Working Group over the first 8 years of its existence with an emphasis on lessons learned throughout the process. It is hoped that in addition to the published methods of the Working Group, the lessons we have learned along the way will be informative to others who are producers and consumers of evidence-based guidelines in the field of genomic medicine.
ISSN:1098-3600
1530-0366
DOI:10.1038/gim.2013.110